Last 12 months
Inside the activity.
1 purchase rows · 2632 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 142 |
| Dec 2025 | 0 | 143 |
| Jan 2026 | 0 | 78 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 364 |
| Apr 2026 | 0 | 346 |
| May 2026 | 1 | 340 |
| Jun 2026 | 0 | 298 |
| Jul 2026 | 0 | 240 |
| Aug 2026 | 0 | 251 |
| Sep 2026 | 0 | 260 |
| Oct 2026 | 0 | 144 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2022 Filed Nov 14, 2022 21:37 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,595 | $262.06 | $417,984.26 |
DisclosureSEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 6 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,772 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $261.78 to $262.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:37 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 823 | $261.16 | $214,934.68 |
DisclosureSEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 5 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,367 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $260.71 to $261.675. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:37 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 949 | $259.86 | $246,609.23 |
DisclosureSEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 4 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,190 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $259.55 to $260.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:37 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 793 | $258.47 | $204,969.01 |
DisclosureSEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 3 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,139 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $258.28 to $258.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:37 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,198 | $257.73 | $308,755.03 |
DisclosureSEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 2 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,932 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $257.19 to $258.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:37 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 8,000 | $113.08 | $904,640.00 |
DisclosureSEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 1 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 09, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 320 | $263.93 | $84,456.16 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 13 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F12 · price: This transaction was executed in multiple trades at prices ranging from $263.83 to $264.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 8,000 | $0.00 Strike: $113.08 | $0.00 |
DisclosureSEC source: 0001415889-22-011289 · form4-11102022_041144.xml · derivative · entry 9 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,000 Underlying: Common Stock · 8,000 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,522 | $266.18 | $405,125.96 |
DisclosureSEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 6 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $265.67 to $266.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 3,386 | $264.96 | $897,140.00 |
DisclosureSEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 5 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $264.625 to $265.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,180 | $264.26 | $311,826.21 |
DisclosureSEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 4 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,038 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $263.61 to $264.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 504 | $262.86 | $132,483.71 |
DisclosureSEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 3 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,218 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $262.59 to $263.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,408 | $262.09 | $369,026.24 |
DisclosureSEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 2 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,722 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $261.525 to $262.515. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 8,000 | $113.08 | $904,640.00 |
DisclosureSEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 1 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 00:03 UTC |
Olian Judy D.Director
|
SaleCommon Stock | 600 | $265.09 | $159,054.00 |
DisclosureSEC source: 0001415889-22-011203 · form4-11092022_121115.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,665 Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 8,000 | $0.00 Strike: $113.08 | $0.00 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · derivative · entry 19 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,000 Underlying: Common Stock · 8,000 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 83 | $266.54 | $22,122.82 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 15 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 311 | $265.52 | $82,575.17 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 14 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F13 · price: This transaction was executed in multiple trades at prices ranging from $265.09 to $265.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 3,812 | $263.25 | $1,003,515.48 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 12 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 844 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F11 · price: This transaction was executed in multiple trades at prices ranging from $262.81 to $263.793. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,709 | $262.30 | $448,262.84 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 11 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,656 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F10 · price: This transaction was executed in multiple trades at prices ranging from $261.79 to $262.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,765 | $261.21 | $461,031.77 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 10 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,365 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F9 · price: This transaction was executed in multiple trades at prices ranging from $260.765 to $261.745. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 8,000 | $113.08 | $904,640.00 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 9 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 07, 2022 Filed Nov 7, 2022 21:30 UTC |
Mesa NildaDirector
|
SaleCommon Stock | 290 | $268.57 | $77,885.71 |
DisclosureSEC source: 0001415889-22-011113 · form4-11072022_041101.xml · nonDerivative · entry 1 Mesa Nilda · CIK 0001756697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,180 Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 00:03 UTC |
Olian Judy D.Director
|
GiftCommon Stock | 1,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-011203 · form4-11092022_121115.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,265 F1 · price: Bona fide charitable contribution to a donor advised fund. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 21:30 UTC |
DWEK RAYMONDDirector
|
Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001415889-22-011178 · form4-11082022_041101.xml · derivative · entry 3 DWEK RAYMOND · CIK 0001231617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 21:30 UTC |
DWEK RAYMONDDirector
|
Disposition to issuerCommon Stock | 5,000 | $266.80 | $1,334,000.00 |
DisclosureSEC source: 0001415889-22-011178 · form4-11082022_041101.xml · nonDerivative · entry 2 DWEK RAYMOND · CIK 0001231617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 21:30 UTC |
DWEK RAYMONDDirector
|
Exercise / conversionCommon Stock | 5,000 | $88.03 | $440,150.00 |
DisclosureSEC source: 0001415889-22-011178 · form4-11082022_041101.xml · nonDerivative · entry 1 DWEK RAYMOND · CIK 0001231617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
EDGEMOND JAMESCFO AND TREASURER
|
Exercise / conversionShare Tracking Award · Derivative | 2,411 | $0.00 Strike: $94.96 | $0.00 |
DisclosureSEC source: 0001415889-22-011244 · form4-11092022_041154.xml · derivative · entry 6 EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Share Tracking Award · 2,411 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
EDGEMOND JAMESCFO AND TREASURER
|
Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $52.12 | $0.00 |
DisclosureSEC source: 0001415889-22-011244 · form4-11092022_041154.xml · derivative · entry 5 EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Share Tracking Award · 5,000 shares Expires 2023-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
EDGEMOND JAMESCFO AND TREASURER
|
Disposition to issuerCommon Stock | 2,411 | $266.80 | $643,254.80 |
DisclosureSEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 4 EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384 F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
EDGEMOND JAMESCFO AND TREASURER
|
Exercise / conversionCommon Stock | 2,411 | $94.96 | $228,948.56 |
DisclosureSEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 3 EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
EDGEMOND JAMESCFO AND TREASURER
|
Disposition to issuerCommon Stock | 5,000 | $266.80 | $1,334,000.00 |
DisclosureSEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 2 EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384 F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
EDGEMOND JAMESCFO AND TREASURER
|
Exercise / conversionCommon Stock | 5,000 | $52.12 | $260,600.00 |
DisclosureSEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 1 EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F2 · balance_after: Includes 23 shares acquired on September 4, 2019, 297 shares acquired on March 4, 2020, 156 shares acquired on March 4, 2021, 58 shares acquired on September 3, 2021, 97 shares acquired on March 4, 2022 and 26 shares acquired on September 2, 2022, under the United Therapeutics Corporation Employee Stock Purchase Plan. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 8,000 | $0.00 Strike: $113.08 | $0.00 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · derivative · entry 18 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,000 Underlying: Common Stock · 8,000 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 805 | $269.75 | $217,150.92 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 8 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F8 · price: This transaction was executed in multiple trades at prices ranging from $269.39 to $269.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,627 | $268.71 | $437,190.19 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 7 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F7 · price: This transaction was executed in multiple trades at prices ranging from $268.39 to $269.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,544 | $267.78 | $681,225.20 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 6 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,562 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $267.33 to $268.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,151 | $266.96 | $574,230.10 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 5 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,106 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $266.33 to $267.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 365 | $265.79 | $97,014.19 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 4 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,257 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $265.25 to $266.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 276 | $264.22 | $72,924.72 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 3 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,622 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $264.11 to $264.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 232 | $263.52 | $61,135.48 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 2 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,898 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $263.11 to $263.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:31 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 8,000 | $113.08 | $904,640.00 |
DisclosureSEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 1 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 8,000 | $0.00 Strike: $113.08 | $0.00 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · derivative · entry 25 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 984,000 Underlying: Common Stock · 8,000 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 259 | $267.95 | $69,398.38 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 21 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F20 · price: This transaction was executed in multiple trades at prices ranging from $267.86 to $268.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 767 | $267.35 | $205,056.91 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 20 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F19 · price: This transaction was executed in multiple trades at prices ranging from $266.80 to $267.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 335 | $266.18 | $89,170.97 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 19 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,156 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F18 · price: This transaction was executed in multiple trades at prices ranging from $265.69 to $266.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,098 | $264.99 | $555,956.78 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 18 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,491 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F17 · price: This transaction was executed in multiple trades at prices ranging from $264.63 to $265.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 4,144 | $264.21 | $1,094,871.32 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 17 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,589 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F16 · price: This transaction was executed in multiple trades at prices ranging from $263.62 to $264.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 397 | $262.84 | $104,347.56 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 16 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,733 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. F15 · price: This transaction was executed in multiple trades at prices ranging from $262.19 to $263.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2022 Filed Nov 4, 2022 22:05 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 8,000 | $113.08 | $904,640.00 |
DisclosureSEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 15 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.